[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Human Milk Oligosaccharides (HMO) Market 2017 Forecast to 2022

January 2018 | 115 pages | ID: G1F80D2F1E8EN
GlobalInfoResearch

US$ 4,880.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan?s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.
Scope of the Report:

This report focuses on the Human Milk Oligosaccharides (HMO) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
  • Abbott
  • Inbiose
  • Company two
  • Jennewein Biotechnologie
  • Glycom
  • ZuChem
  • Dextra Laboratories
Market Segment by Regions, regional analysis covers
  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Neutral
  • Acidic
Market Segment by Applications, can be divided into
  • Food Industry
  • Laboratory Research
There are 15 Chapters to deeply display the global Human Milk Oligosaccharides (HMO) market.

Chapter 1, to describe Human Milk Oligosaccharides (HMO) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Milk Oligosaccharides (HMO), with sales, revenue, and price of Human Milk Oligosaccharides (HMO), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Milk Oligosaccharides (HMO), for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW

1.1 Human Milk Oligosaccharides (HMO) Introduction
1.2 Market Analysis by Type
  1.2.1 Neutral
  1.2.2 Acidic
1.3 Market Analysis by Applications
  1.3.1 Food Industry
  1.3.2 Laboratory Research
1.4 Market Analysis by Regions
  1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Abbott
  2.1.1 Business Overview
    2.1.1.1 Abbott Human Milk Oligosaccharides (HMO) Description
    2.1.1.2 Abbott Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.1.2 Abbott Human Milk Oligosaccharides (HMO) Product Introduction
    2.1.2.1 Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Abbott Human Milk Oligosaccharides (HMO) Product Introduction
  2.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.1.3.1 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Abbott Human Milk Oligosaccharides (HMO) Market Share in Global in 2016
2.2 Inbiose
  2.2.1 Business Overview
    2.2.1.1 Inbiose Human Milk Oligosaccharides (HMO) Description
    2.2.1.2 Inbiose Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.2.2 Abbott Human Milk Oligosaccharides (HMO) Product Introduction
    2.2.2.1 Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Inbiose Human Milk Oligosaccharides (HMO) Product Introduction
  2.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.2.3.1 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Inbiose Human Milk Oligosaccharides (HMO) Market Share in Global in 2016
2.3 Company two
  2.3.1 Business Overview
    2.3.1.1 Company two Human Milk Oligosaccharides (HMO) Description
    2.3.1.2 Company two Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.3.2 Company two Human Milk Oligosaccharides (HMO) Product Introduction
    2.3.2.1 Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Company two Human Milk Oligosaccharides (HMO) Product Introduction
  2.3.3 Company two Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.3.3.1 Company two Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Company two Human Milk Oligosaccharides (HMO) Market Share in Global in 2016
2.4 Jennewein Biotechnologie
  2.4.1 Business Overview
    2.4.1.1 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Description
    2.4.1.2 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.4.2 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Product Introduction
    2.4.2.1 Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Product Introduction
  2.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.4.3.1 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Market Share in Global in 2016
2.5 Glycom
  2.5.1 Business Overview
    2.5.1.1 Glycom Human Milk Oligosaccharides (HMO) Description
    2.5.1.2 Glycom Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.5.2 Glycom Human Milk Oligosaccharides (HMO) Product Introduction
    2.5.2.1 Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Glycom Human Milk Oligosaccharides (HMO) Product Introduction
  2.5.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.5.3.1 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Glycom Human Milk Oligosaccharides (HMO) Market Share in Global in 2016
2.6 ZuChem
  2.6.1 Business Overview
    2.6.1.1 ZuChem Human Milk Oligosaccharides (HMO) Description
    2.6.1.2 ZuChem Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.6.2 ZuChem Human Milk Oligosaccharides (HMO) Product Introduction
    2.6.2.1 Production Bases, Sales Regions and Major Competitors
    2.6.2.2 ZuChem Human Milk Oligosaccharides (HMO) Product Introduction
  2.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.6.3.1 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 ZuChem Human Milk Oligosaccharides (HMO) Market Share in Global in 2016
2.7 Dextra Laboratories
  2.7.1 Business Overview
    2.7.1.1 Dextra Laboratories Human Milk Oligosaccharides (HMO) Description
    2.7.1.2 Dextra Laboratories Human Milk Oligosaccharides (HMO) Headquarter, Main Business and Finance Overview
  2.7.2 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Introduction
    2.7.2.1 Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Introduction
  2.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share
    2.7.3.1 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Dextra Laboratories Human Milk Oligosaccharides (HMO) Market Share in Global in 2016

3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET COMPETITION, BY MANUFACTURER

3.1 Global Human Milk Oligosaccharides (HMO) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Human Milk Oligosaccharides (HMO) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Human Milk Oligosaccharides (HMO) Manufacturer Market Share
  3.4.2 Top 5 Human Milk Oligosaccharides (HMO) Manufacturer Market Share
3.5 Market Competition Trend

4 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET ANALYSIS BY REGIONS

4.1 Global Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Regions
  4.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Regions (2012-2017)
  4.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Regions (2012-2017)
4.2 North America Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
4.3 Europe Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
4.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
4.5 South America Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
4.6 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)

5 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Countries
  5.1.1 North America Human Milk Oligosaccharides (HMO) Sales by Countries (2012-2017)
  5.1.2 North America Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)
  5.1.3 USA Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  5.1.4 Canada Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  5.1.5 Mexico Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
5.2 North America Human Milk Oligosaccharides (HMO) Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 North America Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2016-2017)
  5.2.2 North America Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2016-2017)
5.3 North America Human Milk Oligosaccharides (HMO) Sales by Type (2012-2017)
5.4 North America Human Milk Oligosaccharides (HMO) Sales by Application (2012-2017)

6 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Countries
  6.1.1 Europe Human Milk Oligosaccharides (HMO) Sales by Countries (2012-2017)
  6.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)
  6.1.3 Germany Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  6.1.4 UK Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  6.1.5 France Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  6.1.6 Russia Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  6.1.7 Italy Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
6.2 Europe Human Milk Oligosaccharides (HMO) Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Europe Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2016-2017)
  6.2.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2016-2017)
6.3 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2012-2017)
6.4 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2012-2017)

7 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Countries (2012-2017)
  7.1.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)
  7.1.3 China Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  7.1.4 Japan Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  7.1.5 Korea Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  7.1.6 India Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  7.1.7 Southeast Asia Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
7.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2012-2017)
7.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2012-2017)

8 SOUTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Countries
  8.1.1 South America Human Milk Oligosaccharides (HMO) Sales by Countries (2012-2017)
  8.1.2 South America Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)
  8.1.3 Brazil Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  8.1.4 Argentina Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  8.1.5 Columbia Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
8.2 South America Human Milk Oligosaccharides (HMO) Sales and Revenue (value) by Manufacturers (2016-2017)
  8.2.1 South America Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2016-2017)
  8.2.2 South America Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2016-2017)
8.3 South America Human Milk Oligosaccharides (HMO) Sales by Type (2012-2017)
8.4 South America Human Milk Oligosaccharides (HMO) Sales by Application (2012-2017)

9 MIDDLE EAST AND AFRICA HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Countries (2012-2017)
  9.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Countries (2012-2017)
  9.1.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  9.1.4 UAE Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  9.1.5 Egypt Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  9.1.6 Nigeria Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
  9.1.7 South Africa Human Milk Oligosaccharides (HMO) Sales and Growth (2012-2017)
9.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales and Revenue (value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2012-2017)
9.4 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2012-2017)

10 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SEGMENT BY TYPE

10.1 Global Human Milk Oligosaccharides (HMO) Sales, Revenue and Market Share by Type (2012-2017)
  10.1.1 Global Human Milk Oligosaccharides (HMO) Sales and Market Share by Type (2012-2017)
  10.1.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2012-2017)
10.2 Neutral Sales Growth and Price
  10.2.1 Global Neutral Sales Growth (2012-2017)
  10.2.2 Global Neutral Price (2012-2017)
10.3 Acidic Sales Growth and Price
  10.3.1 Global Acidic Sales Growth (2012-2017)
  10.3.2 Global Acidic Price (2012-2017)

11 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SEGMENT BY APPLICATION

11.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)
11.2 Food Industry Sales Growth (2012-2017)
11.3 Laboratory Research Sales Growth (2012-2017)

12 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET FORECAST (2017-2022)

12.1 Global Human Milk Oligosaccharides (HMO) Sales, Revenue and Growth Rate (2017-2022)
12.2 Human Milk Oligosaccharides (HMO) Market Forecast by Regions (2017-2022)
  12.2.1 North America Human Milk Oligosaccharides (HMO) Market Forecast (2017-2022)
  12.2.2 Europe Human Milk Oligosaccharides (HMO) Market Forecast (2017-2022)
  12.2.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast (2017-2022)
  12.2.4 South America Human Milk Oligosaccharides (HMO) Market Forecast (2017-2022)
  12.2.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Forecast (2017-2022)
12.3 Human Milk Oligosaccharides (HMO) Market Forecast by Type (2017-2022)
12.4 Human Milk Oligosaccharides (HMO) Market Forecast by Application (2017-2022)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source@LOT
LIST OF TABLES AND FIGURES
Figure Human Milk Oligosaccharides (HMO) Picture
Table Product Specifications of Human Milk Oligosaccharides (HMO)
Figure Global Sales Market Share of Human Milk Oligosaccharides (HMO) by Types in 2


More Publications